Form 4: OmniAb CEO Matthew Foehr Executes Stock Transactions Following RSU Vesting

OmniAb CEO Matthew Foehr sold 13,634 shares of common stock at an average price of $4.13 following the vesting of restricted stock units.

Summary

• OmniAb CEO Matthew Foehr vested 26,555 restricted stock units (RSUs) on December 7, 2024.
• These RSUs converted into 26,555 shares of common stock.
• Following the vesting, Mr. Foehr sold 13,634 shares of common stock on December 9, 2024, at an average price of $4.13.
• The sale was to cover tax withholding obligations related to the RSU vesting.
• The total number of shares beneficially owned by Mr. Foehr after these transactions is 3,714,447.
• This total includes 2,926 shares acquired through the company's Employee Stock Purchase Plan (ESPP) on November 29, 2024.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction related to executive compensation. While the sale of shares might cause minor concern, it is a standard practice for tax purposes and does not indicate a significant negative sentiment.

Positives

• The vesting of RSUs indicates a positive compensation structure for the CEO.
• The CEO's continued ownership of a significant number of shares (3,714,447) demonstrates a continued alignment with the company's success.

Negatives

• The sale of 13,634 shares, while for tax purposes, could be perceived negatively by some investors as a reduction in the CEO's direct stake.

Risks

• The sale of shares by a key executive could potentially create short-term market volatility.
• The need to sell shares to cover tax obligations could indicate a potential future pattern of sales upon vesting events.

Industry Context

This type of transaction is common for executives who receive stock-based compensation. The sale of shares to cover tax obligations is a standard practice.

Comparison to Industry Standards

• Executive stock transactions are a common occurrence in publicly traded companies, particularly after vesting periods for equity-based compensation.
• Similar transactions can be seen at companies like Regeneron Pharmaceuticals (REGN) and Amgen (AMGN), where executives regularly manage their stock holdings.
• The sale of shares to cover tax obligations is a standard practice across the industry, and the reported price range of $4.04 to $4.16 is within the expected range for such transactions.

Stakeholder Impact

• Shareholders may have a neutral to slightly negative reaction to the sale of shares by the CEO, although it is a common practice.
• Employees may view the vesting of RSUs as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

OmniAb, Matthew Foehr, stock sale, RSU vesting, insider trading, executive compensation, share ownership, ESPP